Novalis Biotech is an early-stage venture capital investor focusing on enabling technologies in the life sciences. They aim to support innovative healthcare concepts from the incorporation stage, emphasizing capital-light platform technologies and close customer interaction early in the company's lifecycle. The firm focuses on funding, professional/academic connections, and business strategy to create value for all stakeholders, supporting early-stage startups from pre-seed to Series A stages.
Bevorzugte Reifephase für die erste Finanzierung.
innovative research and manufacturing tools, bioinformatics, genomics, diagnostics, digital health
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Standard-Finanzierungsbetrag pro Runde.
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...